Clinton Group’s NEVRO CORP. NVRO Stock Holding History

Clinton Group’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,282	Closed	-$238K	–	1071
2016 Q4	$238K	Sell	3,282 -3,764	-53%	-$322K	0.01%	739
2016 Q3	$736K	Buy	+7,046	New	+$636K	0.03%	575

Other funds holding NVRO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Clinton Group's NVRO Position: Q1 2017 in Review

Clinton Group sold out of NEVRO CORP. (NVRO) in Q1 2017, closing a stake of 3,282 shares — an estimated $238K sold.

Clinton Group first reported a position in NVRO in Q3 2016 and held it in 2 quarters. The position peaked at $736K in Q3 2016. 193 funds tracked by Wall St. Rank hold NVRO as of Q1 2017.

Clinton Group reported no remaining NEVRO CORP. position as of Q1 2017 after selling out during the quarter.
Clinton Group sold 3,282 NEVRO CORP. shares in Q1 2017, an estimated $238K.
Clinton Group first reported a position in NEVRO CORP. in Q3 2016 and held it in 2 quarters.
Clinton Group's NEVRO CORP. position peaked at $736K in Q3 2016.
193 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2017.

Based on Clinton Group's 13F filing for Q1 2017, filed 10 May 2017.